Julia Ruhl
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
KSHV infection of B cells primes protective T cell responses in humanized mice.
Journal: Nature communications
Published: July 03, 2023
Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor Langerin.
Journal: European journal of immunology
Published: October 08, 2021
Chikungunya Virus Envelope Protein E2 Provides a Vector for Targeted Antigen Delivery to Human Dermal CD14+ Dendritic Cells.
Journal: The Journal of investigative dermatology
Published: July 30, 2020
Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Journal: European journal of immunology
Published: March 27, 2020
EBV renders B cells susceptible to HIV-1 in humanized mice.
Journal: Life science alliance
Published: January 06, 2020
Vaccination against the Epstein-Barr virus.
Journal: Cellular and molecular life sciences : CMLS
Published: November 15, 2019
MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo.
Journal: mBio
Published: January 17, 2019
Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
Journal: The Journal of clinical investigation
Published: October 05, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 23, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026